U.S. Department of Health and Human Services Designates Four Nutrients of Public Health Concern Validating Glucose Health, Inc. (OTC: GLUC) Patent Pending Soluble Fiber-Based Nutrition Formulation
Rhea-AI Summary
Glucose Health, Inc. (OTC: GLUC) highlighted the U.S. Department of Health and Human Services (HHS) and USDA's designation of dietary fiber as one of four nutrients of public health concern in their 2020-2025 Dietary Guidelines for Americans. This federal recognition validates the company's strategic focus on fiber-based nutrition products.
The company's flagship brand GlucoDown®, a dietary fiber-infused drink formulated for balanced glucose levels, competes with major brands like Glucerna® and Boost® in national pharmacy chains. Additionally, their Fiber Up® brand, utilizing a variant of their patent-pending formulation, targets digestive and gut health, competing with Metamucil®.
CEO Murray Fleming emphasized that this federal designation aligns with their core mission since 2017, positioning the company to potentially benefit from increased government funding for dietary fiber awareness campaigns and anticipated rising consumer demand.
Positive
- None.
Negative
- Operates in highly competitive market against established brands like Glucerna, Boost, and Metamucil
- Trading on OTC markets rather than major exchanges
News Market Reaction – GLUC
On the day this news was published, GLUC gained 17.65%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BENTONVILLE, Ark., June 30, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a publicly traded company specializing in diabetic nutrition and soluble fiber-based nutrition products, today commented on the U.S. Department of Health and Human Services (HHS) and U.S. Department of Agriculture (USDA) official recognition and designation of dietary fiber as a nutrient of public health concern in the Dietary Guidelines for Americans, 2020–20251.
Dietary fiber is one of four nutrients identified by HHS and USDA as critically under-consumed, to the detriment of the well-being of Americans. This federal designation of public health concern underscores a significant public health deficiency and is expected to drive increased government funding of dietary fiber awareness campaigns leading to follow-on demand for dietary fiber-based nutrition solutions. Among the companies best positioned to benefit from the designation issued by HHS and USDA is Glucose Health, Inc., which began scientific formulation and product development of its now patent pending soluble fiber-based nutrition products in 2017.
Glucose Health, Inc.’s flagship diabetic nutrition brand GlucoDown® is a dietary fiber-infused nutrition drink scientifically formulated to support balanced glucose levels particularly after meals. GlucoDown® competes in the diabetic nutrition category and is found on the shelves of national pharmacy chains alongside products such as Glucerna® (Abbott Laboratories, Abbott, ABT) and Boost® (Nestlé USA, Inc., Nestlé S.A., Nestlé, NSRGY). GlucoDown® offers health-conscious consumers a differentiated focus on providing dietary fiber’s established metabolic benefits via a refreshing beverage offered in powdered drink flavors and iced teas.
Glucose Health, Inc. also utilizes a variant of its patent pending formulation in its brand Fiber Up®, a delicious-tasting powdered beverage dietary fiber supplement targeting digestive and gut health. Scientifically formulated to compete with Metamucil® (The Procter & Gamble Company, P&G, PG), Fiber Up® builds upon the company’s mission to make fiber supplementation effective and enjoyable.
“The federal government’s recognition of dietary fiber as a nutrient of public health concern validates what has been our core mission since 2017” said Murray Fleming, CEO of Glucose Health, Inc. “We anticipated this public health priority and began development work formulating GlucoDown® and Fiber Up® to give consumers effective but still flavorful ways to contribute to their overall metabolic health. We believe Glucose Health, Inc. is uniquely positioned at the intersection of evolving public health priorities and anticipated rising consumer demand.”
1U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans, 2020–2025. 9th Edition. December 2020. Available at https://www.dietaryguidelines.gov

Investor Contact: Investor Relations info@glucosehealthinc.com www.glucosehealthinc.com OTC: GLUC